Provided by Tiger Trade Technology Pte. Ltd.

BioRestorative Therapies, Inc.

2.74
-0.0041-0.15%
Volume:20.56K
Turnover:57.71K
Market Cap:3.78M
PE:-0.13
High:2.82
Open:2.82
Low:2.74
Close:2.74
52wk High:34.60
52wk Low:2.61
Shares:1.38M
Float Shares:1.25M
Volume Ratio:0.88
T/O Rate:1.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-21.2000
EPS(LYR):-31.6731
ROE:-241.14%
ROA:-118.81%
PB:1.25
PE(LYR):-0.09

Loading ...

BioRestorative Therapies Inc trading halted, news pending

TIPRANKS
·
Sep 05

BioRestorative Therapies Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview

Reuters
·
Sep 04

BioRestorative Therapies announces 1-for-20 reverse stock split

TIPRANKS
·
Sep 03

Biorestorative Therapies Announces Reverse Stock Split

Reuters
·
Sep 03

BioRestorative Therapies Announces Reverse Stock Split

THOMSON REUTERS
·
Sep 03

BioRestorative Therapies - Appoints Steven Brown as Chairman of the Board Effective September 1, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 02

BioRestorative Therapies - Katharyn Field Steps Aside as Interim CEO and CFO Effective August 26, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 02

BioRestorative Therapies Inc: Appoints Anna Skowron as Chief Financial Officer, Effective August 27, 2026

THOMSON REUTERS
·
Sep 02

BioRestorative Therapies Switches Auditor to Bush & Associates CPA, Dismisses CBIZ CPAs

Reuters
·
Sep 02

BioRestorative Therapies Gets NASDAQ Notice over Late Filing of Quarterly Report

Reuters
·
Aug 26

BioRestorative Therapies Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview

Reuters
·
Aug 19

BioRestorative Therapies Delays Q2 10-Q Filing After CEO, CFO Resignations

Reuters
·
Aug 15

BioRestorative Therapies: Has not Made Decision to Discontinue Suspended Product Lines - SEC Filing

THOMSON REUTERS
·
Aug 15

BioRestorative Therapies: Conducting Review of the Documentation, Sourcing, Regulatory Status Associated with Suspended Products- SEC Filing

THOMSON REUTERS
·
Aug 15

BioRestorative Therapies: Suspends All Orders, Shipments of Exocr, Biox Biocosmeceutical Product Lines Effective Immediately, on Aug 7 - SEC Filing

THOMSON REUTERS
·
Aug 15

BioRestorative Therapies Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview

Reuters
·
Aug 07

BioRestorative Therapies Director Esha Randhawa Files Initial Beneficial Ownership Statement

Reuters
·
Jul 31

Biorestorative Therapies Files Form 3 Initial Beneficial Ownership Statement for Director Steven Collier Brown

Reuters
·
Jul 25

Biorestorative Therapies - Appoints Katharyn Field as CEO, President, and Interim CFO Effective July 13, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 17

Biorestorative Therapies - Lance Alstodt Resigns as President, CEO, Chairman and All Other Positions Effective July 13, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 17